Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Vireo Growth ( (TSE:VREO) ) has provided an update.
Vireo Growth Inc. has successfully refinanced its existing senior secured debt with a $120 million self-syndicated term loan and expanded its credit facilities with an additional $33 million second lien term loan. This refinancing is expected to save over $10 million annually in interest expenses, strengthening Vireo’s financial position and enhancing shareholder value. The move follows recent mergers that expanded Vireo’s market leadership and reflects a strategic effort to consolidate and optimize debt. The refinancing was well-received by lenders, showcasing confidence in Vireo’s operating model and leadership.
The most recent analyst rating on (TSE:VREO) stock is a Hold with a C$0.55 price target. To see the full list of analyst forecasts on Vireo Growth stock, see the TSE:VREO Stock Forecast page.
More about Vireo Growth
Vireo Growth Inc., founded in 2014, is a pioneering company in the medical cannabis industry. It focuses on building a disciplined and strategically aligned platform, leveraging a national portfolio while maintaining a local presence. The company is committed to its customers, employees, shareholders, industry collaborators, and communities.
Average Trading Volume: 26,505
Technical Sentiment Signal: Sell
Current Market Cap: C$562.4M
Find detailed analytics on VREO stock on TipRanks’ Stock Analysis page.